Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma - Zhou, S. L.; Yue, W. B.; Fan, Z. M.; Du, F.; Liu, B. C.; Li, B.; Han, X. N.; Ku, J. W.; Zhao, X. K.; Zhang, P.; Cui, J.; Zhou, F. Y.; et al. (Diseases of the esophagus, 2014)
Keywords: Adult; Aged; Antigens, Neoplasm - immunology; Antigens, Neoplasm - metabolism; Autoantibodies - blood; autoantibody; Biomarkers, Tumor - immunology; Biomarkers, Tumor - metabolism; Carcinoma, Squamous Cell - diagnosis; Carcinoma, Squamous Cell - immunology; Carcinoma, Squamous Cell - metabolism; Cyclin B1 - immunology; Cyclin B1 - metabolism; Cyclin-Dependent Kinase Inhibitor p16; DNA-Binding Proteins - immunology; DNA-Binding Proteins - metabolism; Early Diagnosis; Esophageal Neoplasms - diagnosis; Esophageal Neoplasms - immunology; Esophageal Neoplasms - metabolism; Esophageal Squamous Cell Carcinoma; Female; Humans; Inhibitor of Apoptosis Proteins - immunology; Inhibitor of Apoptosis Proteins - metabolism; Male; Middle Aged; Neoplasm Proteins - immunology; Neoplasm Proteins - metabolism; precancerous lesion; RNA-Binding Proteins - immunology; RNA-Binding Proteins - metabolism; Survivin; Transcription Factors - immunology; Transcription Factors - metabolism; Tumor Suppressor Protein p53 - immunology; Tumor Suppressor Protein p53 - metabolism; tumor-associated antigen (TAA); esophageal squamous cell carcinoma; precancerous lesion; autoantibody; tumor-associated antigen (TAA)